Microvascular Dysfunction in Ischemia with No Obstructive Coronary Arteries (INOCA): Pathophysiology, Diagnosis, and
Sidhartha Senapati1, Joel Shah1, Lakshmi Kattamuri1
1Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, Texas, USA.
Insights
Ischemia with No Obstructive Coronary Arteries (INOCA) involves small vessel dysfunction, not main artery blockages. Identifying INOCA type with specific tests improves angina management and quality of life.
Area of Science:
- Cardiology
- Vascular Medicine
- Diagnostic Imaging
Background:
- Ischemia with No Obstructive Coronary Arteries (INOCA) presents as angina and reduced blood flow despite clear major coronary arteries.
- This condition often stems from underlying microvascular dysfunction, inflammation, or oxidative stress.
Purpose of the Study:
- To synthesize current understanding of Ischemia with No Obstructive Coronary Arteries (INOCA) based on recent literature.
- To highlight diagnostic modalities and therapeutic strategies for INOCA.
Main Methods:
- Systematic literature review of studies published between January 2018 and December 2025.
- Inclusion of research on Coronary Flow Reserve (CFR), Index of Microcirculatory Resistance (IMR), and novel treatments for INOCA.
Main Results:
- Coronary Microvascular Dysfunction (CMD) in INOCA can be attributed to endothelial dysfunction, inflammation, and oxidative stress.
- Diagnostic tools include noninvasive Cardiac Magnetic Resonance (CMR) and invasive assessments like CFR < 2.5, IMR ≥ 25, and acetylcholine provocation.
- Pharmacological treatments such as statins, ACE inhibitors/ARBs, calcium-channel blockers, trimetazidine, and ranolazine can alleviate angina and enhance quality of life.
Conclusions:
- INOCA is characterized by small vessel abnormalities, often missed by standard angiography, necessitating specialized diagnostic approaches.
- Utilizing tests like CFR, IMR, and acetylcholine provocation aids in accurate INOCA diagnosis and tailored treatment strategies.
- Personalized treatment based on INOCA subtype significantly improves patient outcomes, reducing angina and enhancing quality of life.
Introduction:
Ischemia with No Obstructive Coronary Arteries (INOCA) leads to angina and reduced blood flow in people whose main heart arteries are clear.
Methods:
We reviewed articles from PubMed, Scopus, and Web of Science databases for studies published from January 2018 to December 2025 to summarize the current understanding of INOCA. We included studies on Coronary Flow Reserve (CFR), Index of Microcirculatory Resistance (IMR), and new drugs or procedures.
Results:
CMD can be caused by problems that depend on the endothelium as well as by inflammation and oxidative stress. Diagnosis can use noninvasive tests like Cardiac Magnetic Resonance (CMR) imaging or invasive tests such as Coronary Flow Reserve (CFR) below 2.5, Index of Microcirculatory Resistance (IMR) of 25 or more, and acetylcholine provocation. Using treatments like statins, ACE inhibitors or ARBs, calcium-channel blockers, trimetazidine, and ranolazine can help manage angina and improve quality of life.
Discussion:
INOCA is a heart condition where symptoms and risks are caused by problems in the small blood vessels, not by blockages in the main arteries. Standard angiograms may not detect these problems, which can lead to missed diagnoses. Tests such as coronary flow reserve, index of microcirculatory resistance, and acetylcholine provocation can help identify the issue and guide treatment. Recent studies show that treating the specific type of INOCA can reduce angina and improve quality of life.
Conclusion:
INOCA includes several types linked to small vessel problems and spasms, which should be identified using specific tests. Treating patients according to their INOCA type leads to better outcomes.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Ischemic Stroke ll: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations


